Medytox Inc. | MedPath

Global Cerebral Palsy Clinical Trial Landscape Assessed in New 2024 Review

5 months ago

• A new report provides an overview of the global clinical trial landscape for cerebral palsy, including trial numbers and enrollment trends. • The review covers clinical trials by region, country (G7 & E7), phase, trial status, endpoint status, and sponsor type. • The report identifies prominent drugs in ongoing trials and key companies involved in cerebral palsy therapeutics. • It also analyzes unaccomplished trials and enrollment trends over the past five years, offering insights for strategic decision-making.